Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2005

View Archived Issues

Altastaph reported to shorten hospital stay in adult patients with S. aureus bacteremia

Eszopiclone shows efficacy in insomnia associated with MDD

A specific inhibitor of Akt shows antitumor activity and low toxicity in rodents

Antiinflammatory activity of glabridin in a mouse sepsis model

TRPV1 agonist effective against urinary incontinence in preclinical model

Parenteral glutamine reported to increase hsp70 levels in critically ill patients

Melanocortin-4 receptor antagonist potentially useful for the treatment of cachexia

Similar efficacy found for darbepoetin alfa and epoetin alfa in chemotherapy-induced anemia

Data supports development of iroxanadine for cardiovascular diseases

Arimoclomol shows potential for type 2 diabetes in rat studies

Approvable letter for contrast agent MS-325

CR-001 shows potential as antithrombosis drug

Labopharm's once-daily tramadol approved in France

Alvesco launched in U.K.

Enrollment complete in phase I study of Davanat/5-FU

Two new phase II trials evaluate Discovery's Surfactant Replacement Therapy

Evidence suggests an association between resistin and insulin resistance in humans

New data on the pharmacokinetics and pharmacodynamics of oral insulin spray

Tea flavanoid tested in septic shock model

Novel, broad-spectrum chemokine inhibitor shows good pharmacological profile

AstraZeneca patent discloses delta-opioid agonists for pain

Scientists at CSIC report calpain inhibitors

Novel antimitotic compounds in early development at Cytokinetics

Antiinfective agents claimed by Dr. Reddy's

New compositions for cancer diagnosis and therapy

University of Pennsylvania scientists patent new methods for the treatment of cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...